Obesity Today—April 21, 2026
This week’s Obesity update highlights regulatory follow-up, oral treatment…
Endocrinology Today—April 14, 2026
This week’s Endocrinology update highlights regulatory clearances, commercial…
Obesity Today—April 14, 2026
This week’s Obesity update highlights regulatory and commercial momentum,…
Obesity Today—April 7, 2026
This week’s Obesity update highlights regulatory progress, advancing late-stage…
AI in Healthcare and Digital Health Today—April 6, 2026
This week’s Artificial Intelligence and Digital Health update highlights…
Lucid Diligence Brief: Ambrosia Biosciences $100M Series B for oral GLP-1 asset
Lucid Diligence Brief: Ambrosia Biosciences $100M Series B for oral GLP-1……
Obesity Today—March 31, 2026
This week’s Obesity update highlights regulatory progress, advancing late-stage…
Obesity Today—March 24, 2026
This week’s Obesity update highlights regulatory progress, advancing clinical…
Lucid Diligence Brief: Fauna Bio obesity target designation with Lilly
Lucid Diligence Brief: Fauna Bio obesity target designation with Lilly…
Obesity Today—March 17, 2026
This week’s Obesity update highlights regulatory approvals, emerging generic…
Lucid Diligence Brief: Samsung Bioepis and G2GBIO long-acting semaglutide collaboration
Lucid Diligence Brief: Samsung Bioepis and G2GBIO long-acting semaglutide…
Obesity Today—March 10, 2026
This week’s Obesity update highlights regulatory approvals, emerging generic…